Technical Analysis for PDLI - PDL BioPharma, Inc.

Grade Last Price % Change Price Change
grade A 3.11 -1.58% -0.05
PDLI closed down 1.58 percent on Wednesday, January 16, 2019, on 55 percent of normal volume. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Up Up Flat
See historical PDLI trend table...

Date Alert Name Type % Chg
Jan 16 Outside Day Range Expansion 0.00%
Jan 16 Overbought Stochastic Strength 0.00%
Jan 15 Overbought Stochastic Strength -1.58%
Jan 14 NR7 Range Contraction -0.32%
Jan 14 Overbought Stochastic Strength -0.32%
Jan 11 Overbought Stochastic Strength -2.51%
Jan 10 New Uptrend Bullish -2.51%
Jan 10 New 52 Week High Strength -2.51%
Jan 10 Overbought Stochastic Strength -2.51%
Jan 9 New 52 Week Closing High Bullish -2.51%

Older signals for PDLI ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
PDL BioPharma, Inc. engages in intellectual property asset management and patent portfolio and related assets investment activities. The company is involved in the humanization of monoclonal antibodies and the discovery of a new generation of targeted treatments for cancer and immunologic diseases, as well as other medical conditions. It offers Queen et al. patents that cover humanized antibodies, methods for humanizing antibodies, polynucleotide encoding in humanized antibodies, and methods of producing humanized antibodies. The company was formerly known as Protein Design Labs, Inc. and changed its name to PDL BioPharma, Inc. in 2006. PDL BioPharma, Inc. was founded in 1986 and is headquartered in Incline Village, Nevada.
Is PDLI a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 3.22
52 Week Low 2.25
Average Volume 1,885,616
200-Day Moving Average 2.6878
50-Day Moving Average 2.923
20-Day Moving Average 2.938
10-Day Moving Average 3.116
Average True Range 0.1207
ADX 26.85
+DI 21.6771
-DI 11.3327
Chandelier Exit (Long, 3 ATRs ) 2.8579
Chandelier Exit (Short, 3 ATRs ) 2.9021
Upper Bollinger Band 3.3439
Lower Bollinger Band 2.5321
Percent B (%b) 0.71
BandWidth 27.631042
MACD Line 0.0831
MACD Signal Line 0.0617
MACD Histogram 0.0213
Fundamentals Value
Market Cap 479.18 Million
Num Shares 154 Million
EPS 0.44
Price-to-Earnings (P/E) Ratio 7.07
Price-to-Sales 3.18
Price-to-Book 0.56
PEG Ratio 0.35
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 3.29
Resistance 3 (R3) 3.30 3.26 3.26
Resistance 2 (R2) 3.26 3.21 3.25 3.25
Resistance 1 (R1) 3.18 3.18 3.16 3.17 3.24
Pivot Point 3.14 3.14 3.13 3.13 3.14
Support 1 (S1) 3.06 3.09 3.04 3.05 2.98
Support 2 (S2) 3.02 3.06 3.01 2.97
Support 3 (S3) 2.94 3.02 2.96
Support 4 (S4) 2.93